1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Brigatinib
Trade Name:
Alunbrig
Manufacturer/Distributor:
Takeda Canada Inc.
www.takeda.com/en-ca
Classification:
Antineoplastic agent
ATC Class:
B01XE43 - brigatinib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/07/26
Date Marketed in Canada (yyyy/mm/dd):
2018/07/26
Presentation:
Tablet: 30 mg. DIN: 02479206
Tablet: 90 mg. DIN: 02479214
Tablet: 180 mg. DIN: 02479222
Comments:
Notice of compliance with conditions for treatment of adults with anaplastic lymphoma kinase positive metastatic non-small cell lung cancer.
Source:
Product monograph
Back to:
Drug Product Listings 
